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ABSTRACT
Background: Mitral valve repair is well established as 
the preferred treatment modality for the majority of 
patients with degenerative mitral valve disease requiring 
intervention. Valve repair offers a distinct event-free sur-
vival advantage compared with replacement with either 
a bioprosthetic or mechanical valve. At present, there 
are little data available on the management and out-
come of mitral valve repair in South Africa. The aim of 
this study is to describe and compare the indications, 
specifi c pathology and outcomes of patients accepted 
for mitral valve repair. Internationally published fi gures 
for peri-operative mortality are less than 2% for degen-
erative mitral regurgitation, with a freedom from mitral 
valve reoperation of 94% at 10 years.
Methods: All patients referred for mitral valve repair at 
Tygerberg Hospital, Cape Town, South Africa, between 
1 December 2010 and 30 June 2015, were retrospectively 
included. Demographic characteristics, cardiovascular 
risk factors, pre-operative (NYHA) functional class, the 
pre- and post-operative transthoracic and transoeso-
phageal echocardiograms, immediate in hospital mor-
tality and 6-month post-surgical mortality and functional 
class were analysed. Repair failure was defi ned as either 
intra-operative conversion to MVR or need for reopera-
tion at 6 months.
Results: A total of 147 patients were referred for mitral 
valve repair, of which 114 patients were accepted for 
mitral valve repair by the local heart team. In total, 106 
of the 114 patients underwent surgical intervention, 
6 defaulted their surgical dates, and 2 refused surgery. 
Of those accepted for surgery, 57.9% were males, 42.1% 
were females, with a mean age of 47.7 years in both 
groups combined, 44.7% had hypertension, 43.9% were 
smokers and 21.1% had concomitant IHD; 56.1% were 
pre-operative NYHA functional class III, 29.8% were 
class II, 7% class IV, and 7% were class I; 60.2% had a 
6-month post-operative NYHA functional class I, 32.3% 
had class II, 5.4% class III, and 2.2% had class IV. Mitral 
valve prolapse (MVP) with fl ail segment due to chord 
rupture was the predominant etiology (29%); P2 was the 
most common segment involved (36%), followed by A2 
(29.8%). For MVP, including patients with infective endo-
carditis, the mortality rate was 4.8% at 30 days and 
6 months. The overall mortality rates for all patients 
accepted for mitral valve repair were 4.7% and 6.6% at 30 
days and 6 months respectively. Freedom from reopera-
tion was 98% at 6 months. There was a signifi cant associa-
tion between bileafl et involvement and mitral valve 
repair failure (p=0.006). Chordal insertion with annulo-
plasty was the most common intervention used (45.5%). 
Conclusion: Mitral valve prolapse was the predominant 
etiology in patients referred for mitral valve repair.  The 
mortality rate for mitral valve repair in the prolapse 
group was 4.8% at 6 months. Chordal insertion with 
annuloplasty was the most common intervention used. 
Bileafl et involvement was found to be an independent 
risk factor for repair failure. The mortality rate for all 
patients accepted for mitral valve repair was 6.6% at 
6 months.  SAHeart 2018;15:182-189
INTRODUCTION
Degenerative mitral valve prolapse (MVP) as a clinical entity has 
only been recognised for some 50 years, since Barlow and 
colleagues  proposed that mid to late systolic clicks and apical 
late systolic murmurs were of mitral valve origin.(1) In a study of 
the Framingham Offspring Study cohort, the prevalence of 
mitral valve prolapse was 2.5%, and it is now recognised as the 
most common cause of chronic mitral regurgitation with more 
than 150 million people affected worldwide.(2,3) Echocardio-
graphically, mitral valve prolapse is characterised by excessive 
leaflet motion, defined as displacement of any part of the mitral 
valve leaflet to ≥2mm above the mitral annular plane.(2) 
The natural history of mitral valve prolapse is extremely vari-
able and is largely determined by the severity of mitral regur-
gitation (MR).(2) Although the majority of patients remain 
asymptomatic and may have a near normal life expectancy, 
approximately 5% - 10% have progression to severe mitral 
regurgitation, which has a mortality rate approaching 6% - 7% 
per year.(4-6) Internationally published figures of peri-operative 
mortality for mitral valve repair is less than 2% for degenerative 
mitral regurgitation, and ranges from 5% - 10% for functional 
(ischaemic) mitral regurgitation.(7)   
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Degenerative MVP is considered as a spectrum rather than 
an entity, and it is responsible for the syndromes of mitral 
valve thickening with bileaflet prolapse (Barlow’s syndrome), 
MVP and flail leaflet. The pathology of these is mainly caused 
by 2 processes – myxomatous degeneration and fibroelastic 
deficiency.(8,9) Myxomatous degeneration is typically seen in 
younger individuals and is recognised by thickening of the 
mitral leaflets (>5mm) on echocardiography, with associated 
prolapse of the mitral valve (usually bileaflet). Fibroelastic 
deficiency, on the other hand, is seen in elderly patients and is 
characterised on echocardiography by normal leaflet thickness 
with either prolapse or chordal rupture and flail segments.(8,9) 
The management of severe MR has changed dramatically with 
the development of surgical mitral valve repair introduced by 
Alain Carpentier.(10) Mitral valve repair is now well established 
and is the standard of care for patients with mitral valve pro-
lapse due to degenerative mitral valve disease.(11) Repair has a 
distinct advantage in terms of event-free survival compared 
with replacement with a bioprosthetic or mechanical valve.(12) 
Matching echocardiographic findings to the appropriate surgical 
skill level is required to consistently deliver a durable repair. 
Different surgical techniques are used, including leaflet resection, 
plication, implantation of artificial chords, and leaflet reduction. 
Most modern techniques incorporate restrictive annuloplasty 
with an annuloplasty ring, as it supports the repair and improves 
the durability thereof.(2)
The current practice at Tygerberg Hospital (TBH), Cape Town, 
South Africa, for the management of patients with mitral valve 
prolapse requiring surgical intervention, is based on interna-
tional studies and guidelines.(7,13,17) Data on the management 
and outcomes of mitral valve prolapse requiring surgical inter-
vention in South Africa are limited.
METHODS
This is a retrospective, descriptive study of all patients referred 
for mitral valve repair at TBH between 1 December 2010 and 
30 June 2015. The start date was chosen to coincide with the 
introduction of an electronic image database for storage and 
review of all echocardiography studies at TBH (ECHOPAC 
image Vault, GE Healthcare) – to ensure access to and quality 
control of all echocardiograms of participants included in the 
study.  The end date was chosen to allow for the study defined 
follow up of all patients included, and is therefore 5 months 
short of 5 years. The patient’s clinical notes, echocardiogram 
assessment and surgical records were retrieved from the rele-
vant databases.
Patient demographics, including age, gender, race, address, 
cardiovascular risk factors, medical history and pre-operative 
(NYHA) functional class, were obtained from the clinical notes 
prior to surgery. In addition, specif ic parameters were 
obtained from the pre-operative transthoracic and trans-
oesophageal echocardiograms pertaining to assessment of the 
etiology, mechanism of mitral valve disease, and the severity of 
mitral regurgitation. 
Data relating to the surgical process were also collected, 
including: time from acceptance to performance of surgery, 
type of surgical repair, associated CABG, post-operative trans-
thoracic echocardiogram, in hospital mortality, and post-
operative hospital stay. The outcomes at 6 months from 
index surgery were compared to internationally published 
results. 
STATISTICAL ANALYSIS
IBM SPSS version 23 was used to analyse the data. A p value 
<0.05 was considered as statistically significant. Categorical 
variables were described using frequency tables and percent-
ages. Continuous data were checked for normality of distribu-
tion and summarised with mean and standard deviation if 
found to be plausibly normally distributed or with median and 
interquartile range if skewed. Associations between categorical 
variables were tested with the Pearson’s chi square test or 
Fisher’s exact test, if the chi square assumptions were not met. 
ETHICAL ASPECTS
The research was in accordance with the Belmont Report 
guidelines for the protection of human research subjects, and 
was approved by Stellenbosch University’s Research Ethics 
Committee. A waiver of informed consent was approved 
based on the retrospective nature of the study, the fact that 
patients were not subjected to any study-specific investigations 
or interventions beyond routine clinical care, and because 
patient anonymity could be ensured. 
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RESULTS
One hundred and forty seven (147) patients were referred for 
mitral valve repair in the study period, of which 33 were not 
accepted for repair by the local heart team. One hundred and 
fourteen (114) patients were accepted for mitral valve repair 
between 1 December 2010 and 30 June 2015, of which 106 
patients underwent surgical intervention, 6 defaulted their 
surgical dates, and 2 refused surgery. Of those who under-
went surgical intervention, ninety six (96) patients had mitral 
valve repair and 10 had intra-operative switch to mitral 
valve replacement (Figure 1).
Of those accepted for surgery, 66 patients (57.9%) were males, 
48 patients (42.1%) were females, and they had a mean age of 
47.7 years; 57% of patients were of mixed ancestry, 22.8% 
were African, 19.3% white, and 0.9% were undetermined.
Seventy five patients (65.8%) originated from rural areas, and 
39 patients (34.2%) from urban areas.
Cardiovascular risk factors and past medical history 
(Table 1)
Fifty one patients (44.7%) had hypertension, 11 (9.6%) suffered 
from diabetes mellitus type II, 18 (15.8%) had hypercholes-
terolaemia, 50 (43.9%) were smokers, 8 (7%) had previous 
cerebrovascular accidents (CVA), 17 (14.9%) had atrial fibril-
lation, and 24 (21.1%) had IHD.
Pre- and post-operative NYHA functional class at 
6 months
Sixty four patients (56.1%) had a pre-operative NYHA func-
tional class III, 34 (29.8%) were class II, 8 (7%) were class IV, and 
the rest (7%) were class I (Figure 2).
Fifty six patients (60.2%) had a 6-month post-operative NYHA 
functional class I, 30 (32.3%) were class II, 5 (5.4%) class III, and 
only 2 (2.2%) were class IV (Figure 3).
Etiology of mitral valve disease
The predominant etiology was mitral valve prolapse with flail 
segment due to chord rupture (29%) (Figure 4).
Pre-operative transthoracic and transoesophageal 
echocardiogram parameters
The echocardiographic parameters used in the study are illus-
trated in Table 2.
The estimated systolic pulmonary pressure was normal in 44 
patients (38.6%), mildly elevated in 13 patients (11.4%), 
moderate in 17 patients (14.9%), severe in 34 patients (29.8%) 
MITRAL VALVE REPAIR SURGERY
FIGURE 1: Flow chart of patients referred for mitral 
valve repair and their outcomes.
6 Defaulted and 
2 refused surgery
10 Intraoperative switch 
to mitral valve 
replacement
7 Patients demised
147 Patients referred for 
mitral valve repair
114 Patients accepted 
for mitral valve repair
106 Underwent surgical 
intervention
96 Patients underwent 
mitral valve repair
89 Patients alive at 
6 months
33 Patients turned down 
for repair surgery
TABLE I: Demographics and cardiovascular risk factors.
Demographics Number (n) Percentage
Gender
Female 48 42.1%
Male 66 57.9%
Race
Mixed 
ancestry
65 57.0%
African 26 22.8%
White 22 19.3%
Other 1 0.9%
Address
Urban 39 34.2%
Rural 75 65.8%
CV risk factors Number (n) Percentage
Hypertension 51 44.7%
Diabetes 11 9.6%
Hypercholesterolaemia 18 15.8%
Smoking 50 43.9%
Family History 9 7.9%
IHD 24 21.1%
Stroke 8 7.0%
CABG 1 0.9%
Atrial Fibrillation 17 14.9%
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and was undetermined in 6 patients (5.3%). The degree of 
mitral regurgitation pre-operatively was severe in 101 patients 
(86.8%) and of moderate degree in 15 patients (13.2%). 
The underlying etiology of MR in the moderate degree group 
was congenital heart disease (6), ischaemic MR (5), infective 
endocarditis with large vegetation on MV (3), and post trau-
matic (1) (Table 3). The primary indication for surgery in these 
patients was not the mitral regurgitation. The repair of the 
mitral valve in these cases was done at the time of surgery for 
the primary indication, according to current guidelines.(17)
There were 38 patients (33.3%) with posterior leaflet involve-
ment, 37 (32.5%) with anterior leaflet involvement, and 25 
patients (21.9%) with bileaflet involvement. With regard to 
segment involvement, P2 was the most common segment 
involved (36%) (Figures 5 and 8).
Comparison of the pre-operative echocardiographic 
parameters with the immediate and 6 month post-
operative fi ndings
All echocardiograms available at each follow-up time point 
were included in the analysis. Immediately post-operative, 102 
echocardiograms were available as 4 patients had died peri-
operatively before their echocardiograms were done. A fifth 
patient died 2 weeks post-operatively to account for the 5 
early deaths. Only 71 patient echocardiograms were available 
at 6 months; 26 patients were evaluated clinically and no 
echocardiogram was requested at follow-up, and 2 patients 
defaulted follow up. Both the latter patients were contacted 
telephonically for mortality data. The echocardiographic para-
meters assessed at each time point were significantly different 
from pre-operative values (p<0.001), with the exception of 
the pulmonary pressure, in which only the 6 month post-opera-
tion time point was significantly different from pre-operation 
(p<0.001). There was a significant reduction in both LVED 
and LVES post-operatively – the former also showing an imme-
diate post-operative reduction.  Functional parameters such as 
LVEF and TAPSE decreased immediately post-operatively, 
with partial recovery at 6 months when compared to pre-op 
values (Figure 6). 
Class III
6%
Class II
32% Class I
60%
Class IV
2%
FIGURE 3: Post-operative NYHA functional class at 
6 months.
FIGURE 2: Pre-operative NYHA functional class.
Class III
56%
Class II
30%
Class I
7%
Class IV
7%
FIGURE 4: Etiology of mitral valve disease.
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Immediate and 6 month post-operative survival
Of the 106 patients that underwent surgical intervention, 5 
died within 30 days (mortality rate 4.7%) and a further 2 at 
6 months post-operative (mortality rate 6.6%). The underlying 
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etiology in those patients that did not survive was MVP (2), 
MVP with flail segment (1), ischaemic MR (3), and AVSD (1) 
with a cleft anterior mitral valve leaflet. The immediate post-
operative survival was 95.3% versus 93.4% at 6 months. The 
mortality rate at 6 months post-operative, excluding those 
with ischaemic MR, was 3.7%, and for those with MVP only as 
the underlying etiology the mortality rate was 4.8%. Freedom 
from reoperation was 98% at 6 months post-operative. Mitral 
valve repair for ischaemic MR was associated with significant 
mortality at 6 months (23%). All patients undergoing mitral 
valve repair for ischaemic MR had simultaneous revascularisation.
TABLE II: Comparison of the pre-operative echocardiographic parameters with the immediate and 6 month 
post-operative findings.
Echocardiographic 
parameters
Pre-operative values Immediate post-operative values
p value
6 month post-operative 
values
p value
n=114 n=102 n=71
mean SD mean SD mean SD
LVED cm LVED cm 1.09cm 5.13cm 0.92cm p<0.001 4.86cm 1.09cm p<0.001
LVES cm LVES cm 1.1cm 4.01cm 1.06cm p<0.001 3.59cm 1.21cm p<0.001
EF % EF % 11.77% 50.49% 13.09% p<0.001 55.61% 12.66 % p=0.004
LA area cm2 LA area cm2 11.49cm2 22.44cm2 7.82cm2 p<0.001 21.63cm2 7.57cm2 p<0.001
TAPSE TAPSE 0.64cm 1.19cm 0.39cm p<0.001 1.54cm 0.38cm p<0.001
E' m/s E' m/s 0.03m/s 0.07m/s 0.03m/s p<0.001 0.07m/s 0.03m/s p<0.001
Sa m/s Sa m/s 0.03m/s 0.07m/s 0.02m/s p<0.001 0.07m/s 0.02m/s p<0.001
TABLE III: Severity of MR in percentage at 3 time points.
Severity
of  MR None Mild Moderate Severe
Pre-
operative
- - 13.2% 86.8%
6 month 
post- 
operative
40.2% 49% 10.8% -
Address 25.3% 59.1% 12.7% 2.9%
FIGURE 5: Scallop involvement.
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FIGURE 6: Comparison of the pre-operative echo-
cardiographic parameters with the immediate and 
6 month post-operative fi ndings.
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FIGURE 8: Leafl et involvement versus successful repair.
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Successful versus failed repairs
In total there were 12 (11.2%) failed repairs, in which 10 
patients were switched intra-operatively from mitral valve 
repair to replacement with either a bioprosthesis or a mecha-
nical valve, and 2 had redo surgery. Eight patients in the failed 
repair group had bileaflet involvement. Of the 10 patients 
requiring intra-operative switch to mitral valve replacement, 
5 had mitral valve prolapse with a flail segment due to chord 
rupture, 3 had infective endocarditis, and 2 had rheumatic 
heart disease as the cause of MR. Both of the patients 
requiring reoperation had complicated repairs for infective 
endocarditis and submitral aneurysm respectively, and both 
had subsequent mitral valve replacement. There was a signifi-
cant association between bileaflet involvement and mitral 
valve repair failure (p=0.006), with those having failed repairs 
being more likely to have bileaflet prolapse or involvement 
(Figure 8). There was no significant association between the 
pathological segment involved and failed repair. Time from 
acceptance to performance of surgery was quite variable, 
ranging from 0 days - 193 days, and with a median of 48 days. 
There was no difference in median time between those who 
failed and those who had a successful repair.
Post-operative MR
The majority of patients had trace/mild mitral regurgitation at 
6 months post-surgery. Only 2 patients had severe MR at 
6 months after complicated repairs for infective endocarditis 
and a submitral aneurysm respectively.  Both had redo surgery, 
with subsequent mitral valve replacement (Table 3).
Type of surgical repair  
Most patients (87.7%) had an annuloplasty ring inserted as 
part of the mitral valve repair strategy. Chordal insertion was 
favoured as a strategy for repair (45.3%). The graph above 
demonstrates the percentage of patients with different types 
of surgical intervention (Figure 9); 12 patients had concomi-
tant tricuspid valve repair (11.3%) in the form of a tricuspid 
annuloplasty ring.
DISCUSSION 
Mitral valve repair is associated with an operative mortality of 
approximately 3%, depending on the population and the 
pre-operative risk of patients undergoing surgery.(14,15) Interna-
FIGURE 7: Comparison of the pre-operative ejection 
fraction with the immediate and 6 month post- 
operative fi ndings.
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FIGURE 9: Percentage of patients with different types 
of surgical intervention.
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tionally published figures for peri-operative mortality are less 
than 2% for degenerative mitral regurgitation, with a freedom 
from mitral valve reoperation of 94% at 10 years.(7) In our 
series, the mortality rate for MVP was 4.8% at 30 days and 
6 months – which is higher than the published data. The 
mortality rate at 30 days and 6 months post-operative for all 
repairs irrespective of etiology was 4.7% and 6.6% respec-tively, 
with ischaemic MR as the main cause of increased mortality. 
Ischaemic MR is well known to have a significantly higher 
operative mortality than MVP. To our surprise, other etiologies 
included in this cohort – i.e. infective endocarditis and sub-
mitral aneurysms – were not associated with a significant 
increase in mortality. This might be due to selection bias, with 
patients with more advanced involvement not accepted/
considered for mitral valve repair. In our cohort, the 6 month 
mortality rate of patients undergoing surgery for ischaemic 
MR was higher than reported mortality rates (23% vs. 10%).(7) 
Given the limited number of patients undergoing surgery for 
ischaemic MR in our cohort, no clear conclusion can however 
be drawn from this.  Freedom from reoperation was 98% 
at 6 months, which is similar to the published literature.(7,13) 
Surprisingly, there was no association between functional class 
and survival in our cohort. 
There was a significant improvement in symptoms at 6 months 
post-operative. NYHA functional class improved dramatically, 
most patients were asymptomatic (60%), and only a few had 
significant symptoms at 6 months (8%). The etiology in this 
group was mitral valve prolapse due to flail segment (3), 
infective endocarditis (3), and ischaemic MR (1). Echocardio-
graphic parameters were in keeping with the functional class 
improvement, with statistically significant improvement in 
mean LVED from 5.74cm - 4.8cm, LVES from 4cm - 3.6cm and 
recovery of LVEF at 6 months to pre-surgical values (58% vs. 
56%). There was a significant improvement in pulmonary pres-
sure at 6 months. 
Mitral valve prolapse with flail segment due to chord rupture 
was the most common etiology. This correlates with the 
frequent use of chordal implantation with annuloplasty ring 
insertion as a surgical technique in our cohort. High rates of 
repair success were accomplished with low rates of severe 
mitral regurgitation immediately post-operatively (0%). This 
was maintained at 6 months, with only 2 patients documented 
to have severe mitral regurgitation at 6 month follow-up. Both 
of these patients required reoperation (2%), which is 
comparable to published data. In the literature, reoperation to 
treat recur-rent mitral regurgitation after primary repair is 
required in approximately 0.5% - 1.5% of patients per year.(6)   
Isolated P2 prolapse was the most common segment involved 
(36%), and it correlates with international figures where up to 
60% of patients referred for mitral valve repair have P2 pro-
lapse.(2) P2 segment repair carries the highest rate of success-
ful repair.(2) There were 38 patients (33.3%) with posterior 
leaflet involvement, 37 patients (32.5%) with anterior leaflet 
involvement, and 25 patients (21.9%) with bileaflet involve-
ment. Our study demonstrated similar involvement of the 
posterior and anterior leaflet; posterior leaflet involvement is 
more common according to the published literature.(16)
There was a significant association between bileaflet involve-
ment and mitral valve repair failure (p=0.006) – with those 
having failed repairs being more likely to have bileaflet 
involvement.  
Patients undergoing surgery for moderate MR (n=15/13.2%) 
had another primary indication for surgery, and the mitral 
valve was repaired at the time of addressing the primary 
pathology. This group included patients with congenital heart 
disease with moderate MR (6), ischaemic MR at the time of 
CABG (5), infective endocarditis with large vegetations (3), and 
1 patient with traumatic mitral valve injury.  
STUDY LIMITATIONS
This is a small cohort of patients undergoing mitral valve 
repair – in particular only a small number of patients underwent 
surgery for secondary (ischaemic) MR. The high mortality rate 
in this group should be interpreted with caution.
Conclusions drawn from retrospective analyses such as this 
should be made with caution, as it is often very difficult to 
control for all forms of bias. In this regard, one particular 
shortcoming in the echocardiographic analysis is the large 
cohort of patients for which a 6-month echocardiogram is not 
available. Most of these patients (26 of 28) were clinically 
evaluated at 6 months post-surgery, and no echocardiogram 
was requested – presumably due to the combination of a 
good immediate post-operative result on echocardiogram 
and good symptomatic status at follow up. Information on the 
exact circumstance related to the events leading up to the 
patients who died was not available, making it difficult to draw 
conclusions regarding cause of death. 
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CONCLUSION
Mitral valve prolapse was the predominant etiology in patients 
referred for mitral valve repair. The mortality rate for mitral 
valve repair in the prolapse group was 4.8% at 6 months. 
Chordal insertion with annuloplasty was the most common 
intervention used. Bileaflet involvement was found to be an 
independent risk factor for repair failure. The mortality rate 
for all patients accepted for mitral valve repair was 6.6% at 
6 months.
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